Ghrelinomimetic vs Thymosin Alpha-1

Overview

Ghrelinomimetic is primarily a healing & recovery peptide, while Thymosin Alpha-1 is used for immune support.

This page compares Ghrelinomimetic and Thymosin Alpha-1 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Ghrelinomimetic is categorised under Healing & Recovery, while Thymosin Alpha-1 falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Ghrelinomimetic: not FDA-approved; treated as a research compound. Thymosin Alpha-1: not FDA-approved; treated as a research compound.

Dosing. Ghrelinomimetic is typically dosed at 100-200 mcg (daily). Thymosin Alpha-1 is typically dosed at 1.6-3.2 mg (twice weekly).

Can you stack them?

Some protocols combine peptides, but stacking Ghrelinomimetic and Thymosin Alpha-1 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Ghrelinomimetic and Thymosin Alpha-1?

Ghrelinomimetic is primarily a healing & recovery peptide, while Thymosin Alpha-1 is used for immune support. Ghrelinomimetic is not FDA-approved; generally classified as a research compound, whereas Thymosin Alpha-1 is not FDA-approved; generally classified as a research compound.

What is Ghrelinomimetic used for?

Appetite and healing support.

What is Thymosin Alpha-1 used for?

Potent immune modulator.

Can you take Ghrelinomimetic and Thymosin Alpha-1 together?

Some users combine peptides within a single protocol, but stacking Ghrelinomimetic and Thymosin Alpha-1 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Ghrelinomimetic or Thymosin Alpha-1 FDA-approved?

Ghrelinomimetic is not FDA-approved; generally classified as a research compound. Thymosin Alpha-1 is not FDA-approved; generally classified as a research compound.